Camber Capital Management LP Merck & Co., Inc. Transaction History

Camber Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$83.49 - $94.64 $125 Million - $142 Million	-1,500,000 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$73.51 - $82.4 $73.5 Million - $82.4 Million	-1,000,000 Reduced 40.0%	1,500,000 $123 Million
Q4 2021 Feb 14, 2022	BUY	$72.28 - $90.54 $72.3 Million - $90.5 Million	1,000,000 Added 66.67%	2,500,000 $192 Million
Q2 2021 Aug 16, 2021	BUY	$70.31 - $77.77 $35.2 Million - $38.9 Million	500,000 Added 50.0%	1,500,000 $117 Million
Q1 2021 May 17, 2021	BUY	$68.86 - $81.11 $68.9 Million - $81.1 Million	1,000,000 New	1,000,000 $77.1 Million

3,833

1.87B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $255B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Camber Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Camber Capital Management LP with notifications on news.